Pozo-Rosich, Patricia
Martínez-García, Alba
Pascual, Julio
Ignacio, Emilio
Guerrero-Peral, Ángel L.
Balseiro-Gómez, José
Porta-Etessam, Jesús
Latorre-González, Germán
Layos-Romero, Almudena
Lucas, César
Mira, José J.
Article History
Received: 25 January 2019
Accepted: 6 June 2019
First Online: 25 June 2019
Ethics approval and consent to participate
: Research Ethic Committee named CEIM Valladolid Este, Valladolid, Spain.All procedures followed were in accordance with the ethical standards of the responsible committee on human research (institutional and national) and with the Helsinki Declaration of 1964 and its later amendments.
: Not applicable.
: Patricia Pozo-Rosich has received honoraria as a consultant and speaker for Allergan, Amgen, Almirall, Chiesi, Eli Lilly, Medscape, Novartis, and Teva. Her research group has received research grants from Allergan and has received funding for clinical trials from Alder, electroCore, Eli Lilly, Novartis, and Teva.Ignacio E has been a consultant for Novartis y Abbvie, with whom he is currently collaborating in a research project.Angel L Guerrero has been speaker or scientific advisor for Allergan, Novartis and Teva, and Primary investigator for Alder, Amgen, Lilly, Novartis and Teva.J. Balseiro has been a consultant for Allergan, UCB and Biogen, with Biogen is currently collaborating in a research project.Dr. Germán Latorre González is consultant for Novartis, Chiesi, Allergan and Teva and is currently conducting clinical research with Novartis, Allergan and Teva.Almudena Layos has been a consultant for Novartis y Abbvie, with whom he is currently collaborating in a research project.JJM has been a consultant for Janssen Cilag and MSD Spain, with whom he is currently collaborating in a research project.